BioSpace News Archive

The FDA ODD granted is broader than the Company’s original application for kidney transplantation, recognizing the pernicious consequences of IRI in all solid organ transplantation.

Updated Lifileucel Data from Cohort 2 in C-144-01 Clinical Study Initial Data for Lifileucel in Combination with Pembrolizumab in Immune Checkpoint Inhibitor Naïve Advanced Melanoma Cohort 1A in IOV-COM-202 Clinical Study

Expanding portfolio of solutions and capabilities addressing growing need for curated scientific data and expertise to accelerate discovery

Authors on the paper were Olivia Jones, BS, Xiaoqian Cheng, PhD, Saravana R.K. Murthy, PhD, Lawan Ly, BS, Taisen Zhuang, PhD, Giacomo Basadonna, MD/PhD, Michael Keidar, PhD and Jerome Canady, MD.

Challenge participants presented solutions aimed at improving patient outcomes and reducing time between diagnosis and treatment for lung cancer patients

Xtrava Health, a health technology company, announced it has been awarded a $6.2 million contract by the National Institutes of Health under the Rapid Acceleration of Diagnostics initiative to expedite the launch of its SPERA™ COVID-19 antigen test.

Genesis Therapeutics, a company pioneering AI technologies to create medicines for patients with severe and unmet medical needs, today announced the appointment of Will McCarthy as chief business officer.

Biotage AB , on April 28, 2021, held its Annual General Meeting. Due to the extraordinary situation as a result of the Covid-19 pandemic, the Annual General Meeting was carried out through advance voting only, without any physical attendance.

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announced the publication of preclinical research in Nature which suggests that enhancing meningeal lymphatic drainage could improve clinical outcomes for Alzheimer’s disease, either alone or in combination with passive immunotherapies such as antibodies directed at amyloid beta.

Pixee Medical Receives FDA Clearance for Knee + Digitally augmented surgeons are to become a reality in the USA Focus on total knee arthroplasty in ambulatory surgery centers